NIRVF (Nirvana Life Sciences) Other Operating Expense: $0.15 Mil (TTM As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Nirvana Life Sciences Other Operating Expense?

Nirvana Life Sciences NIRVF Other Operating Expense is $0.15 Mil as of Jan. 2026. The stock has 3 warning signs investors should review.

Nirvana Life Sciences's Other Operating Expense for the three months ended in Jan. 2026 was $0.04 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jan. 2026 was $0.15 Mil.

Nirvana Life Sciences's quarterly Other Operating Expense stayed the same from Jul. 2025 ($0.04 Mil) to Oct. 2025 ($0.04 Mil) and stayed the same from Oct. 2025 ($0.04 Mil) to Jan. 2026 ($0.04 Mil).

Nirvana Life Sciences's annual Other Operating Expense declined from Apr. 2023 ($0.29 Mil) to Apr. 2024 ($0.18 Mil) and declined from Apr. 2024 ($0.18 Mil) to Apr. 2025 ($0.16 Mil).

Nirvana Life Sciences Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Nirvana Life Sciences's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nirvana Life Sciences Other Operating Expense Chart

Nirvana Life Sciences Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Apr22 Apr23 Apr24 Apr25
Other Operating Expense
Get a 7-Day Free Trial 0.21 0.39 0.29 0.18 0.16

Nirvana Life Sciences Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.04 0.04 0.04 0.04

Nirvana Life Sciences Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $0.15 Mil mean?
Nirvana Life Sciences (NIRVF) has a Other Operating Expense of $0.15 Mil as of Jan. 2026. Other operating expenses that a company records on its income statement. View historical data on Nirvana Life Sciences and its competitors.
Is Nirvana Life Sciences' Other Operating Expense too high?
Nirvana Life Sciences' current Other Operating Expense is $0.15 Mil.
How does Nirvana Life Sciences' Other Operating Expense compare to VRTX and REGN?
Nirvana Life Sciences' Other Operating Expense of $0.15 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Nirvana Life Sciences and its competitors. Nirvana Life Sciences's current Other Operating Expense is $0.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nirvana Life Sciences stock overvalued right now?
Nirvana Life Sciences (NIRVF) has a current Other Operating Expense of $0.15 Mil. The current Other Operating Expense is $0.15 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Nirvana Life Sciences (NIRVF), the current Other Operating Expense is $0.15 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nirvana Life Sciences Business Description

Other Exchanges NIRV.X:Canada
Address 650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8
Nirvana Life Sciences Inc is a Canada-based company, which is engaged in the scientific research and development of therapeutic products derived from psychedelics. The Company is also focused on developing methodologies for standardized, quality-controlled extraction and purification of psychoactive compounds. The Company operates in a single reportable segment: research and development of therapeutic products derived from psychedelics. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.